Form 4: Protagonist Therapeutics CEO Sells Shares and Exercises Options

Protagonist Therapeutics CEO, Dinesh V. Patel, sold a significant number of shares and exercised stock options, according to a recent SEC filing.

Summary

• Dinesh V. Patel, CEO of Protagonist Therapeutics, engaged in multiple transactions involving the company's stock.
• On November 25, 2024, Mr. Patel sold 78,520 shares at an average price of $46.96, with individual sales ranging from $46.50 to $47.47.
• He also donated 7,000 shares to a donor-advised fund.
• Additionally, Mr. Patel exercised stock options to acquire 1,727 shares at $21.58 per share.
• On November 26, 2024, he sold another 21,480 shares at an average price of $46.25, with individual sales ranging from $44.49 to $46.50.
• Following these transactions, Mr. Patel directly owns 408,455 shares of Protagonist Therapeutics.

Sentiment

Score: 5

Explanation: The document reflects standard insider trading activity. While the share sales could be seen as slightly negative, the option exercise is a positive sign. Overall, the sentiment is neutral.

Positives

• The CEO exercised stock options, indicating confidence in the company's future.

Negatives

• The CEO sold a significant number of shares, which could be interpreted negatively by some investors.

Risks

• Large sales of shares by a company's CEO can sometimes lead to a decrease in investor confidence.
• The market may react negatively to the CEO's share sales.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• SEC Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The level of detail provided in the filing is typical for such disclosures, including the range of prices for share sales.

Stakeholder Impact

• Shareholders may react to the CEO's share sales, potentially impacting the stock price.
• The charitable donation of shares may have a positive impact on the recipient organization.

Key Dates

Keywords

Protagonist Therapeutics, Dinesh V. Patel, stock sale, stock options, SEC Form 4, insider trading, share transaction